Litcius/Paper detail

The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis

M Calafato, Isabelle Austin-Zimmerman, Johan H. Thygesen, Mani Sairam, Antonio Metastasio, Louise Marston, Francisco Abad‐Santos, Anjali Bhat, Jasmine Harju‐Seppänen, Haritz Irizar, Eirini Zartaloudi, Elvira Bramon

2020The Pharmacogenomics Journal18 citationsDOI

Topics & Concepts

HyperprolactinaemiaCYP2D6Meta-analysisAntipsychoticGenotypingAdverse effectMedicineRisperidonePharmacologyInternal medicineBiologyProlactinGenotypeSchizophrenia (object-oriented programming)GeneticsCytochrome P450PsychiatryGeneMetabolismHormonePituitary Gland Disorders and TreatmentsPharmacogenetics and Drug MetabolismSchizophrenia research and treatment
The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis | Litcius